Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Increases By 715.4%
Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Increases By 715.4%
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) was the recipient of a large growth in short interest in January. As of January 31st, there was short interest totalling 10,600 shares, a growth of 715.4% from the January 15th total of 1,300 shares. Based on an average daily trading volume, of 34,100 shares, the days-to-cover ratio is presently 0.3 days.
PURE Bioscience, Inc.（OTCMKTS: PURE — 获取评级）是1月份空头利率大幅增长的受益者。截至1月31日，空头利率共计10,600股，较1月15日的1300股总额增长了715.4％。根据34,100股的平均每日交易量，目前的天数与覆盖率为0.3天。
PURE Bioscience Stock Performance
纯生物科学股票表现
PURE Bioscience stock remained flat at $0.12 during midday trading on Friday. 6,412 shares of the company were exchanged, compared to its average volume of 27,970. PURE Bioscience has a 12 month low of $0.07 and a 12 month high of $0.24. The company has a market capitalization of $13.36 million, a price-to-earnings ratio of -3.00 and a beta of 0.25. The stock has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.17.
周五午盘交易中，PURE Bioscience的股票持平至0.12美元。该公司交易了6,412股股票，而平均交易量为27,970股。PURE Bioscience创下12个月低点0.07美元，12个月高点为0.24美元。该公司的市值为1336万美元，市盈率为-3.00，beta值为0.25。该股的50天简单移动平均线为0.11美元，两百天简单移动平均线为0.17美元。
PURE Bioscience (OTCMKTS:PURE – Get Rating) last posted its quarterly earnings data on Wednesday, December 14th. The company reported ($0.01) earnings per share for the quarter. PURE Bioscience had a negative return on equity of 135.85% and a negative net margin of 206.26%. The firm had revenue of $0.47 million during the quarter.
PURE Bioscience（OTCMKTS: PURE — 获取评级）最后一次发布季度收益数据是在12月14日星期三。该公司报告了本季度每股收益（0.01美元）。PURE Bioscience的股本回报率为负135.85％，负净利润率为206.26％。该公司在本季度的收入为47万美元。
Hedge Funds Weigh In On PURE Bioscience
对冲基金权衡纯生物科学
PURE Bioscience Company Profile
纯生物科学公司简介
(Get Rating)
（获取评分）
PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
PURE Bioscience, Inc从事用于病原体和卫生控制的专有抗菌产品的发现、开发和商业化。它提供基于柠檬酸二氢银的消毒和消毒产品。该公司由迈克尔·克拉尔于1992年8月24日创立，总部位于加利福尼亚州库卡蒙格牧场。
Read More
阅读更多
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
- Wall Street Says These 3 Stocks Will Grow Earnings In 2023
- 免费获取 StockNews.com 关于 PURE Bioscience (PURE) 的研究报告
- Snowflake 会玩艰难的雪橇，想保持拉力赛活力吗？
- Cloudflare 股票已触底
- 引领模因股票复苏的 3 只股票
- 微软-动视暴雪合并：驾驭风险与回报
- 华尔街称这三只股票将在2023年增加收益
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收《纯生物科学日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收PURE Bioscience及相关公司的最新新闻和分析师评级的简明每日摘要。
译文内容由第三方软件翻译。